Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M

Slides:



Advertisements
Similar presentations
Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication.
Advertisements

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial  Marieke J.
Age at menarche: a predictor of diminished ovarian function?
Soyoung Bae, M.D., Joseph Karnitis, M.D.  Fertility and Sterility 
Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Bjørn Bay, M. D. , Erik Lykke Mortensen, M. Sc
Thyroid antibodies and gestational diabetes mellitus: a meta-analysis
Michael M. Alper, M.D.  Fertility and Sterility 
Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis 
Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles  Angela R. Baerwald, Ph.D.,
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained.
Medical treatment of ectopic pregnancy: a committee opinion
Orhan Bukulmez, M. D. , Qin Li, M. S. , Bruce R. Carr, M. D
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers  Andrea.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility  Alexander M. Quaas, M.D.,
Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with.
Ellen W. Freeman, Ph. D. , Clarisa R. Gracia, M. D. , Mary D
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Oocyte cryopreservation
Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.
Do anti-mullerian hormone levels predict ovarian reserve in SLE patients presenting for hematopoietic stem cell transplant?  H. Browne, A. Armstrong,
Deleterious effect of tobacco on IVF outcome and ovarian reserve as reflected by serum anti mullerian hormone (AMH)  P. Barriere, T. Freour, D. Masson,
Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Clomiphene citrate at 50: the dawning of assisted reproduction
Ovarian hyperstimulation secondary to ectopic secretion of follicle-stimulating hormone. Literature review prompted by a case  Jorge Burgos, M.D., Patricia.
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study  Carlo.
Evaluation of diagnostic testis biopsy and the repetition of testicular sperm extraction surgeries in infertility patients  Alayman Hussein, M.B.B.C.H.,
Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity  Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.
MaryFran Sowers, Ph. D. , Daniel McConnell, Ph. D
Clinical uses of anti-Müllerian hormone assays: pitfalls and promises
P-425 Fertility and Sterility Volume 86, Issue 3, (September 2006)
Effectiveness of highly purified human menopausal gonadotropin vs
Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D
Heterotopic autotransplantation of cryobanked human ovarian tissue as a strategy to restore ovarian function  S.Samuel Kim, M.D., In-Tak Hwang, M.D.,
Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women.
L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing 
Fertility and Sterility: an evaluation
Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify.
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Sedigheh Borna, M.D., Azita Nasery, M.D.  Fertility and Sterility 
Ovarian cystic teratoma with a pathognomonic appearance of multiple floating balls: a case report and investigation of common characteristics of the cases.
Current evaluation of amenorrhea
A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child  Xin Chen, M.D., M.Sc., Shi-ling Chen,
Fertility and Sterility
Serum anti-Mullerian hormone dynamics during stimulated cycles by aromatase inhibitor anastrozole and clomiphene citrate in women with infertility  H.-H.
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
In vitro sildenafil citrate use as a sperm motility stimulant
Self-reported behavioral and socioemotional functioning of 11- to 18-year-old adolescents conceived by in vitro fertilization  Karin Wagenaar, M.Sc.,
Performance of basal follicle-stimulating hormone and patient's age in the prediction of poor ovarian response and IVF outcome of women who developed.
Early menopause in mothers of children with Down syndrome?
Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation  Janet F. McLaren, M.D., Richard O. Burney,
A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.
Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization  Rongrong Tan, M.M.Sc., Danhua Pu,
Is chromosome testing of the second miscarriage cost saving
Presentation transcript:

Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve  Janet Kwee, M.D., Roel Schats, M.D., Ph.D., Joseph McDonnell, M.Sc., Axel Themmen, Ph.D., Frank de Jong, Ph.D., Cornelis Lambalk, M.D., Ph.D.  Fertility and Sterility  Volume 90, Issue 3, Pages 737-743 (September 2008) DOI: 10.1016/j.fertnstert.2007.07.1293 Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Plot of the number of follicles obtained after stimulation against the basal AMH. The three lines represent the regression line, with the 95% CI of the mean appearing as well. Fertility and Sterility 2008 90, 737-743DOI: (10.1016/j.fertnstert.2007.07.1293) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.